Company / PP&E (Net)
LIFECORE BIOMEDICAL, INC. \DE\ PP&E (Net) History
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$200.0M
FY2019
5-year range
$84.5M / $200.0M
FY2015-FY2019
Trend
+25.3%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $121M to $200M over the past 2 years.
Based on SEC 10-K filings.
$200M in FY2019 with a 5-year CAGR of +22.0%.
Improved from $121M to $200M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +18.3%
- 5-Year CAGR
- +22.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +22.0%, indicating consistent growth.
- In FY2019, pp&e (net) increased 25.3% year-over-year.
- Lowest pp&e (net) in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2019 | $200.0M | +25.3% |
| FY2018 | $159.6M | +32.1% |
| FY2017 | $120.9M | +0.0% |
| FY2016 | $120.9M | +43.1% |
| FY2015 | $84.5M | +13.9% |
| FY2014 | $74.1M | +12.7% |
| FY2013 | $65.8M | +3.6% |
| FY2012 | $63.5M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026